Company profile · Onderzoeks- & kennisinstelling
Amphera B.V.
- Biotechnology
- Onderzoeks- & kennisinstelling
- 's-Hertogenbosch
- Biotechnology · 's-Hertogenbosch
- Employees
- 11–50
- Founded
- 2012
- Province
- Noord-Brabant
- Country
- Netherlands
About Amphera B.V.
Amphera is a late-stage biotechnology company developing cell therapies to treat cancer. MesoPher is comprised of autologous dendritic cells loaded with PheraLys, a lysate of tumour cell lines. PheraLys contains a broad repertoire of tumour-associated antigens, many of which are present in pancreatic cancer and other cancers.
Keywords
- Dendritic Cell Therapy
- Immuno-Oncology
- Mesothelioma
- Pancreatic Cancer
Address
Headquarters
's-HertogenboschNoord-Brabant, Netherlands
Team by function
Based on 1 public job profiles as of 4 September 2026.
- Manufacturing / Production1
Similar companies
Companies with a similar profile, Noord-Brabant first.
Prolepha Research B.V.
Pharmaceuticals · Rijsbergen
2–10 employeesView profile
Acerta Pharma B.V. A member of the AstraZeneca Group
Pharmaceuticals · Oss
51–200 employeesView profile
APO-T BV
Biotechnology · Oss
2–10 employeesView profile
UPyTher
Biotechnology · Eindhoven
2–10 employeesView profile
Amgen Netherlands
Biotechnology · Breda
10,001+ employeesView profile
AM-Pharma
Biotechnology · Utrecht
11–50 employeesView profile